Business News

Russia Launches "First" Coronavirus Vaccine Successfully

Russia has become the first country to come up with a vaccine offering “ sustainable immunity” against coronavirus. Russia had been working hard to develop this vaccine since long and would now produce it in large numbers within weeks.

By theMUStime

Russia Launches "First" Coronavirus Vaccine Successfully

Russia has become the first country to come up with a vaccine offering “ sustainable immunity” against coronavirus. Russia had been working hard to develop this vaccine for long and would now produce it in large numbers within weeks. 

Coronavirus, a global threat, has been taking a toll on the global economy. It has caused the demise of 735,000 people around the world to date. The cases are escalating day by day without a halt. Total cases count to 20,011,186 worldwide since its origin in China’s Wuhan.

Simultaneously, many scientists and medical experts are buckling down to develop a vaccine against Coronavirus. Around 160 countries had been working for the production of vaccines against Coronavirus and 27 of them were done with initial stages of human trials. 

Vladimir Putin, President of Russia, mentioned today during a video conference with government ministers, “ This morning, for the first time in the world, a vaccine against the new Coronavirus was registered.”

Is The Vaccine Safe?

Putin’s daughter has been the first one to be inoculated, which proves the vaccine to be fit for human use to some extent. The vaccine has been developed in Gamaleya National Research Centre in Moscow tested at 12 separate locations in Russia. 

Though many scientists and medical experts around the world have been skeptical as the vaccine has been approved by the health ministry before its Phase III trial which involves thousands of participants. Alexander Gintsburg, director of the Gamaleya National Research Centre assured that the vaccine cannot harm the body as they don’t show any multiplication. 

The first stage of research at Sechenov University was conducted by a group of 18 volunteers and the second group involved 20 volunteers.

According to reports, Chief researcher Elena Smolyarchuk told a Russian news agency that the human trials have been completed at the university and they will be discharged soon.

Though there is no update if it can enter commercial production. 



What does WHO say? 

Russia was advised earlier this month by the World Health Organisation to consider all the established guidelines and develop a vaccine

including all the necessary “ Development Stages”, as any compromise with the safety of the vaccine can intensify the spread of the virus. 

The vaccine is developed with an adenovirus-based viral vector vaccine which is combined with the SARS-CoV-2 virus to induce an immune response in the body.

  The USA has the most number of Coronavirus cases (5,254,561) followed by Brazil  ( 3,057,470).  Almost 213 countries have been affected by a coronavirus, therefore, the countries have put all the efforts to develop a vaccine to battle coronavirus. Though Oxford University & drugmaker AstraZeneca had developed an experimental coronavirus vaccine earlier but haven’t yet completed the Phase III trials, however, Sources says, Russia seems to be in a hurry to launch the vaccine to have an upper hand in the market.

If Russia's vaccine is successful, then we will have to see critically whether it is safe and effective. India has the capacity for mass production of vaccines”, says AIIMS Director Randeep Guleria. 




What's Your Reaction?

like
3
dislike
0
love
1
funny
0
angry
0
sad
0
wow
0